SYSTEM ONLINE

The operating system
for cardiac AI
commercialization

CardiaXOS runs competitive intelligence, clinical partnership tracking, and go-to-market operations for a local-first cardiology AI company. Autonomous. Daily. While the founder closes deals at ACC.

$14.2B
Cardiology AI Market by 2034
1,200+
FDA-Cleared AI Devices
0
Competitors With Local LLM + Cardiology Focus
The Gap

Every cardiology AI sends patient data to the cloud. That's the problem.

Hospital CIOs reject cloud-dependent cardiac AI tools because patient imaging data is too sensitive to leave the network. HeartFlow, Idoven, Glass Health, they all require cloud connectivity. The result: cardiology departments are underserved by AI that actually respects their security posture. OpenCardio changes that with a fully local LLM that never transmits patient data.

What CardiaXOS Tracks

Everything the founder needs,
running while he's at the booth

CI

Competitive Intelligence

Monitors HeartFlow's IPO filing, CASIS product updates, new FDA clearances, and CPT code changes in cardiology AI. Daily briefings, zero manual scanning.

PL

Pipeline Management

Tracks clinical partnerships, hospital procurement conversations, and demo follow-ups from ACC.26 and WHX 2026. No leads fall through the cracks.

MR

Market Research

Synthesizes clinical evidence on LLM performance in cardiology, regulatory shifts, and reimbursement pathway updates. Research that would take days, delivered overnight.

GO

GTM Operations

Cold outreach to cardiology department heads and CIOs at privacy-conscious hospital systems. Personalized, researched, and sent on schedule.

The founder runs the product.
CardiaXOS runs everything else.

An autonomous operating system purpose-built for scaling clinical AI in the most regulated market on earth.